Advertisement

Topics

Companies Related to "2017 Molecular Blood Typing Grouping Infectious Disease Market" [Most Relevant Company Matches] RSS

20:39 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "2017 Molecular Blood Typing Grouping Infectious Disease Market" found in our extensive corporate database of over 50,000 company records.

Showing "2017 Molecular Blood Typing Grouping Infectious Disease Market" Companies 1–25 of 8,000+

Relevant

HistoGenetics

HistoGenetics provides cost-effective HLA sequence-based typing services based on the latest state-of-the-art robotics and bioinformatics technologies for donor registries, pharmacogenomics, donor centers, cord blood typing, transplant centers, and HLA laboratories around the world. Through a proprietary process developed by Dr. Soo Young Yang and Dr. Nezi...


GenoVision Inc

GenoVision is an innovative biotechnology company with extensive expertise in HLA/tissue typing ranging from sample preparation to advanced analysis. The GenoVision Group was founded in 1998 and acquired by Qiagen in June 2002. Qiagen has incorporated the nucleic acid technologies and products of GenoVision into their own organization and GenoVision is a stand-alone company with focus o...

Xenomics

Xenomics, Inc. is the developer of next-generation molecular diagnostics products that address important health problems worldwide. Our mission is to apply our proprietary transrenal DNA test platform to develop highly sensitive, truly non-invasive molecular diagnostics that replace outdated blood, sputum, and tissue testing technologies many of which are not sufficiently sensitive and specific, ...


Forensic Analytical Molecular Genetics Division

Comprised of leading research scientists from the field of HLA typing, Forensic Analytical's Molecular Genetics Division offers a variety of products and services that address the needs of immu-nologists, virologists, and histocompatibility testing laboratories worldwide. Forensic Analytical's HLA reagent kits are designed for sequencing on ABI instruments. All of the kits are made with absolute f...

GenArraytion, Inc.

Based in Rockville, Md., GenArraytion, Inc. is a privately held, veteran-owned, small business dedicated to the development and commercialization of multiplexed molecular assays for infectious diseases. GenArraytion is dedicated to improving healthcare through the development and distribution of treatment-guiding molecular assays for infectious disease mar...

Quotient Biodiagnostics, Inc.

Quotient Biodiagnostics is the diagnostics division of Quotient Bioscience Group (United Kingdom), and through its wholly owned subsidiary, Alba Bioscience, brings over 30 years experience in the transfusion medicine market to the Group. Quotient will focus on providing innovative, high-quality and cost-effective solutions to the worldwide transfusion medicine market, helping to ensure safe and r...

The Center for Infectious Disease Research

The Center for Infectious Disease Research is the largest independent, nonprofit organization in the U.S. focused solely on infectious disease research. Our mission is to make transformative scientific advancements that lead to the prevention and treatment of infectious diseases. We advance the science to develop vaccines, drugs, and diagnostics for infect...

Center for Infectious Disease Research

Center for Infectious Disease Research is the largest independent, non-profit organization in the U.S. focused solely on infectious disease research. Our mission is to make transformative scientific advancements that lead to the prevention and treatment of infectious diseases. We advance the science to develop vaccines, drugs, and diagnostics for infectiou...

Prominex, Inc.

Prominex was founded in 2016 with a primary focus on the development of molecular diagnostic assays for point-of-care infectious disease testing. The novel molecular amplification and waveguide detection technologies incorporated into our Validex System enables the development of ultrafast, accurate, easy-to-use, highly multiplexed, and low-cost molecular ...

JETA Molecular

JETA Molecular, BV., based in Utrecht, the Netherlands, is a privately-held, molecular testing company focused on the design, development and commercialization of noninvasive reagent and software solutions for transplant monitoring. The Company has commercialized the market leading QTRACE® Analysis System – a qPCR-based reagent and software suite. ...

Great Basin Corporation

Great Basin Corporation is a privately held life sciences company that commercializes breakthrough multiplex chip-based technologies for the molecular, rapid diagnostic testing market. The company is dedicated to development of simple, yet powerful, point-of-care technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases....

Mobidiag

Founded in the year 2000, Mobidiag is specialized in the molecular diagnostics of infectious diseases. The focus area of the company is primarily to develop high-quality content for DNA biochip-based diagnostic assays. Mobidiag has selected clinically relevant panels of bacteria and other infectious disease markers and is developing efficient DNA detection technology for their analysis. Mobidiagâ...

Opsonix, Inc.

Opsonix is developing pathogen-extracting therapies to transform the treatment of blood borne infectious diseases, including sepsis. The company’s proprietary expertise is creating engineered pathogen-capture proteins derived from opsonins, which are natural components of our innate immune system that bind all types of infectious invaders and toxins, ...

Chiron

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop prod...

Chiron Vision

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop prod...

Metabolex Incorporated

Metabolex discovers and develops new drugs for type 2 diabetes, bringing to the market novel drugs that address the molecular mechanisms underlying the disease. Such therapeutics are needed to more effectively control patients' blood glucose levels and impede progression of diabetes and its complications.Metabolex has a team of dedicated experts and a robust technology base in diabetes biology and...

Molecular Templates, Inc.

Molecular Templates is a venture-backed biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics called Engineered Toxin Bodies (ETB) platform technology. The company is pursuing development of various ETBs across a wide range of disease areas including cancer, autoimmune, and infectious disease. F...

Immucor

Established in 1982, Immucor, Inc. was founded by a team of executives with over 200 years of combined blood bank industry experience. The Company's patented Capture® technology received its first license in 1986. This solid phase technology performs antibody screening and identification assays, providing an easy-to-use, standardized test method with improved sensitivity. In addition to manual te...

Teragenix

Teragenix is a provider of innovative Molecular Diagnostic Solutions. Teragenix specializes in products and services that support emerging fields in Molecular Diagnostics, Pharmagenomics and Infectious Disease Management. Teragenix is a privately held corporation based in Fort Lauderdale, Florida.

EraGen Biosciences Inc.

EraGen Biosciences develops, manufactures and markets innovative molecular diagnostic products that are driving a new era in clinical diagnostics and research. The company’s in-market and pipeline products, based on its novel, patented MultiCode® platform chemistry, are the next generation of DNA- and RNA-based testing for the early detection of in...

Smittskyddsinstitutet (SMI)

The Swedish Institute for Infectious Disease Control (SMI) is a government expert authority with a mission to monitor the epidemiology of infectious disease among Swedish citizens and promote control and prevention of these diseases.SMI collaborates with several government authorities and other organisations within the field of infectious disease control and prevention. The most important contacts...

Chiron Corporation

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop prod...

VisEn Medical, Inc.

Over the past decade, breakthrough advances in genomics and proteomics have driven a fundamental evolution in our understanding of the molecular basis of disease. VisEn Medical is developing and commercializing imaging technologies that translate this new knowledge into real-time molecular mapping of disease states in vivo in research, drug development and into the clinic.Founded in 2000, the Comp...

Sea Run Holdings, Inc.

Sea Run Holdings, Inc. is maximizing an opportunity by merging a low margin business (salmon raising) into a high margin business in the biomedical field. The value of the blood per fish could significantly enhance the value of the same fish used for food. Sea Run has shown that salmon blood products can successfully compete against mammalian blood products. Companies in the bovine/human blood fi...

Chemicon International Incorporated

CHEMICON International, Inc. has been in operation since 1981, supplying immunological reagents to the biomedical research community. In 1992, CHEMICON expanded into the area of diagnostic kits and reagents by supplying immunodiagnostic products for antigen detection of infectious disease. CHEMICON recently launched a line of molecular biology products designed for research and clinical applicatio...


More From BioPortfolio on "2017 Molecular Blood Typing Grouping Infectious Disease Market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks